584 related articles for article (PubMed ID: 26170666)
1. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
[TBL] [Abstract][Full Text] [Related]
5. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-Loaded β-Cyclodextrin-Modified Poly(Acrylic Acid) Nanoparticles through Multivalent Inclusion for Anticancer Therapy.
Yuan S; Chen J; Sheng J; Hu Y; Jiang Z
Macromol Biosci; 2016 Mar; 16(3):341-9. PubMed ID: 26611878
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.
Liu K; Chen W; Yang T; Wen B; Ding D; Keidar M; Tang J; Zhang W
Int J Nanomedicine; 2017; 12():8239-8255. PubMed ID: 29180863
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
10. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
[No Abstract] [Full Text] [Related]
11. Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.
Yin L; Xu S; Feng Z; Deng H; Zhang J; Gao H; Deng L; Tang H; Dong A
Biomater Sci; 2017 Mar; 5(4):698-706. PubMed ID: 28184404
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel.
Battogtokh G; Ko YT
Pharm Res; 2014 Nov; 31(11):3019-30. PubMed ID: 24825757
[TBL] [Abstract][Full Text] [Related]
13. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
Wang F; Yang S; Yuan J; Gao Q; Huang C
J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
[TBL] [Abstract][Full Text] [Related]
14. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
15. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
Fülöp Z; Saokham P; Loftsson T
Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
[TBL] [Abstract][Full Text] [Related]
16. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
17. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel.
Bilensoy E; Gürkaynak O; Ertan M; Sen M; Hincal AA
J Pharm Sci; 2008 Apr; 97(4):1519-29. PubMed ID: 17705171
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers.
Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X
Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
20. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
